Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis

Detalles Bibliográficos
Autores principales: de Jesus, Victor Hugo Fonseca, Riechelmann, Rachel P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580714/
https://www.ncbi.nlm.nih.gov/pubmed/34824628
http://dx.doi.org/10.3332/ecancer.2021.1305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580714/
https://www.ncbi.nlm.nih.gov/pubmed/34824628
http://dx.doi.org/10.3332/ecancer.2021.1305

Ejemplares similares